SCHEMBL4305129

SCHEMBL4305129

CCCCCCCCCCCCCC(=O)N1CCN(Cc2ccccc2)C(CC)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.48
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
ABL1 P00519 1/20 0.44
RIN1 Q13671 1/20 0.44
CA1 P00915 4/20 0.43
CA2 P00918 4/20 0.43
CA4 P22748 4/20 0.43
CA9 Q16790 4/20 0.43
EPHX2 P34913 1/20 0.43
FNTA P49354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4301863 1.00 SIGMAR1 (0.48) SIGMAR1ALDH1A1KDM4ELMNAMAPT
SCHEMBL4308949 0.87 CHRM1 (0.49) SIGMAR1LMNAMAPTHPGDABL1
SCHEMBL4307522 0.87 CHRM1 (0.49) SIGMAR1LMNAMAPTHPGDABL1
SCHEMBL4308951 0.84 MEN1 (0.46) MEN1KMT2ACA1CA2CA4
SCHEMBL4301981 0.81 HPGD (0.48) SIGMAR1MAPTHPGDMEN1KMT2A
SCHEMBL4301970 0.81 HPGD (0.48) SIGMAR1MAPTHPGDMEN1KMT2A
SCHEMBL4312869 0.80 CA1 (0.53) LMNAMAPTMEN1KMT2ACA1
SCHEMBL4301386 0.80 CA1 (0.53) LMNAMAPTMEN1KMT2ACA1
SCHEMBL14301937 0.79 HTR7 (0.59) ALDH1A1KDM4ELMNAHPGDHTT
SCHEMBL2131896 0.77 ALDH1A1 (0.60) ALDH1A1KDM4ELMNAHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054398-A1 NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER Korea Research Institute of Bioscience and Biotechnology (KR) 2009-05-06 EP disclosed
WO-2008018778-A1 NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2008-02-14 WO disclosed